|
|
|
News Release
Seattle, WA, June, 2010 - Philips Healthcare and VPDiagnostics, Inc. have signed a co-marketing agreement. Under this agreement, VPDiagnostics will provide its FDA 510 (k) cleared carotid artery atherosclerosis analysis package, called MRI-PlaqueViewTM, for Philips MRI customers. Click product offering for product details. Click more for news details.
Seattle, WA, April, 2010 - VPDiagnostics, Inc. announces the release of plaque analysis software: MRI-PlaqueViewTM 2.0. VPDiagnostics is also actively recruiting clinical sites for an NIH-sponsored multi-center prospectiveclinical trial. more...
NIH/NINDS, February 26th, 2010 - The result of Carotid Revascularization Endartectomy vs. Stenting Trial (CREST): Landmark NIH Clinical Trial Comparing Two Stroke Prevention Procedures Shows Surgery and Stenting Equally Safe and Effective - Opportunities Exist to Target the Treatment to the Patient. more...
Seattle, WA, May, 2009 - VPDiagnostics, Inc. announces that MRI-PlaqueViewTM has been selected as the analysis software for carotid and aorta MRI data in the High-Risk Plaque (HRP) study. The analysis conducted by the University of Washington and Mount Sinai Medical Center has been successfully executed by May 2009.
Seattle, WA, March, 2009 - VPDiagnostics, Inc. announces its new product, MRI-PlaqueViewTM. VPDiagnostics also announces the start of a multi-center clinical trial sponsored by the NIH. more...
Seattle, WA, December, 2008 - VPDiagnostics, Inc announces that MRI-PlaqueViewTM has received 510(k) clearance from the Food and Drug Administration. MRI-PlaqueViewTM provices researchers and clinicians an efficient tool for analyzing magnetic resonance imaging (MRI) of carotid artery atheroslcerosis.
Seattle, WA, April, 2007 - VPDiagnostics, Inc. announced the receipt of a NIH SBIR phase II grant over 3 years. The new funding will be used to complete the commercialization of technology for vessel wall image analysis, with a focus on obtaining regulatory approval for their software.
Seattle, WA, May, 2006 - University of Washington TechTransfer announced today it has licensed a computer-aided cardiovascular analysis system to VPDiagnostics, a Washington state firm.
| |
|
|